Infertility and IVF Unit, Assaf harofeh Medical Center
Zrifin, Israel
Completed
NCT Number: NCT01809366
Effect of Seminal Plasma Insemination on Pregnancy Rates After IVF-ET
Seminal plasma insemination into the vaginal vault of patients undergoing IVF-ET increases uterine receptivity.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–41 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- patients undergoing oocyte pick up for IVF treatment
Exclusion criteria
- endometriosis
- low responders
- uterine malformations
Treatment and study plan
seminal plasma insemination
ProcedurePrimary outcomes
-
implantation rate
Time frame: 4 weeks after ET
Secondary outcomes
-
clinical pregnancy rate
Time frame: 4 weeks after ET
-
ongoing pregnancy rate
Time frame: 6 weeks after ET
Sponsors and collaborators
Lead sponsor
Assaf-Harofeh Medical Center
Other Gov
Registry information
Important dates
- Study start
- 2012
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Mar 12, 2013
- Registry last updated
- Mar 12, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.